In brief, we labeled KPL-4 tumor cells with Vybrant DiD dye, implanted them into the mouse MFPs, treated established tumors with HER2 mAbs, and assessed tumor phagocytosis after 24 hours by flow cytometry. The gene discussed is ERBB2; the disease is neoplasm.